|
Status |
Public on Oct 06, 2023 |
Title |
Integrome signatures of lentiviral gene therapy for SCID-X1 patients |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
Lentiviral vector (LV)-based gene therapy holds promise for a broad range of diseases. Analyzing more than 280,000 vector integration sites (VISs) in 273 samples from 10 patients with X-linked severe combined immunodeficiency (SCID-X1), we discovered shared LV integrome signatures in 9 out of 10 patients in relation to the genomics, epigenomics, and 3D structure of the human genome. VISs were enriched in the nuclear sub-compartment A1 and integrated into super-enhancers close to nuclear pore complexes. These signatures were validated in T cells transduced with an LV encoding a CD19-specific chimeric antigen receptor. Intriguingly, the one patient whose VISs deviated from the identified integrome signatures had a distinct clinical course. Comparison of LV and gamma retrovirus integromes regarding their 3D genome signatures, identified differences that might explain the lower risk of insertional mutagenesis in LV-based gene therapy. Our findings suggest that LV integrome signatures, shaped by common features such as genome organization, may impact the efficacy of LV-based cellular therapies.
|
|
|
Overall design |
To confirm VIS signatures, we performed single-cell profilng for bone marrow samples of two SCID-X1 patients 18 months after gene transfusion.
|
|
|
Contributor(s) |
Yan K, Gottschalk S, Yu J |
Citation(s) |
37801507 |
|
Submission date |
Dec 11, 2020 |
Last update date |
Oct 18, 2023 |
Contact name |
Jiyang Yu |
Organization name |
St Jude Children's Research Hospital
|
Department |
Department of Computational Biology
|
Street address |
262 Danny Thomas Pl
|
City |
Memphis |
State/province |
TN |
ZIP/Postal code |
38105 |
Country |
USA |
|
|
Platforms (1) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (2) |
|
This SubSeries is part of SuperSeries: |
GSE163083 |
Integrome signatures of lentiviral gene therapy for SCID-X1 patients |
|
Relations |
BioProject |
PRJNA684626 |
SRA |
SRP297715 |